| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| SECT-B.ST - | HOLD | 0 @ SEK 21.8437 | SEK 0 | The current share valuation price of SECT-B.ST based on adjusted close was SEK 21.8437. The average price that SECT-B.ST shares were previous bought at was SEK 28.5764. The current market price is -23.6% lower than average price they were purchased at. The value of the holding in SECT-B.ST has fallen by SEK 7,986 (USD $871) compared to the previous valuation of |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 127.5 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 127.5. The average price that IPN.PA shares were previous bought at was EUR 104.662. The current market price is 21.8% higher than average price they were purchased at. The value of the holding in IPN.PA has fallen by EUR 28,552 (USD $33,312) compared to the previous valuation of Ipsen SA |
| LONN.SW - | HOLD | 0 @ CHF 601.563 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 601.563. The average price that LONN.SW shares were previous bought at was CHF 604.613. The current market price is -0.5% lower than average price they were purchased at. The value of the holding in LONN.SW has fallen by CHF 208,895 (USD $261,983) compared to the previous valuation of |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 128.75 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 128.75. The average price that MRK.DE shares were previous bought at was EUR 116.341. The current market price is 10.7% higher than average price they were purchased at. The value of the holding in MRK.DE has fallen by EUR 140,282 (USD $163,667) compared to the previous valuation of Merck KGaA |
| NOVN.SW - | HOLD | 0 @ CHF 121.944 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 121.944. The average price that NOVN.SW shares were previous bought at was CHF 102.38. The current market price is 19.1% higher than average price they were purchased at. The value of the holding in NOVN.SW has fallen by CHF 391,034 (USD $490,411) compared to the previous valuation of |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 51.2948 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 51.2948. The average price that NOVO-B.CO shares were previous bought at was DKK 62.0089. The current market price is -17.3% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has increased by DKK 778,689 (USD $121,596) compared to the previous valuation of Novo Nordisk A/S however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| NSIS-B.CO - | HOLD | 0 @ DKK 56.059 | DKK 0 | The current share valuation price of NSIS-B.CO based on adjusted close was DKK 56.059. The average price that NSIS-B.CO shares were previous bought at was DKK 60.4828. The current market price is -7.3% lower than average price they were purchased at. The value of the holding in NSIS-B.CO has increased by DKK 88,772 (USD $13,862) compared to the previous valuation of however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 62.75 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 62.75. The average price that ORNBV.HE shares were previous bought at was EUR 60.3732. The current market price is 3.9% higher than average price they were purchased at. The value of the holding in ORNBV.HE has fallen by EUR 115,341 (USD $134,568) compared to the previous valuation of Orion Oyj |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 25.64 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 25.64. The average price that PHIA.AS shares were previous bought at was EUR 21.2058. The current market price is 20.9% higher than average price they were purchased at. The value of the holding in PHIA.AS has increased by EUR 6,778 (USD $7,908) compared to the previous valuation of Koninklijke Philips NV however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 48.02 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 48.02. The average price that REC.MI shares were previous bought at was EUR 53.1347. The current market price is -9.6% lower than average price they were purchased at. The value of the holding in REC.MI has fallen by EUR 84,422 (USD $98,495) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA |
| ROG.SW - | HOLD | 0 @ CHF 365.81 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 365.81. The average price that ROG.SW shares were previous bought at was CHF 286.083. The current market price is 27.9% higher than average price they were purchased at. The value of the holding in ROG.SW has fallen by CHF 758,381 (USD $951,115) compared to the previous valuation of |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 80.5 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 80.5. The average price that SAN.PA shares were previous bought at was EUR 88.5053. The current market price is -9.0% lower than average price they were purchased at. The value of the holding in SAN.PA has fallen by EUR 942,479 (USD $1,099,588) compared to the previous valuation of Sanofi SA |
| SDZ.SW - | HOLD | 0 @ CHF 63.5687 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 63.5687. The average price that SDZ.SW shares were previous bought at was CHF 45.334. The current market price is 40.2% higher than average price they were purchased at. The value of the holding in SDZ.SW has fallen by CHF 160,852 (USD $201,731) compared to the previous valuation of |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.17953 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.17953. The average price that HLN.L shares were previous bought at was GBP 4.55196. The current market price is -8.2% lower than average price they were purchased at. The value of the holding in HLN.L has increased by GBP 5,642 (USD $7,597) compared to the previous valuation of Haleon PLC however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| SFZN.SW - | HOLD | 0 @ CHF 88.8502 | CHF 0 | The current share valuation price of SFZN.SW based on adjusted close was CHF 88.8502. The average price that SFZN.SW shares were previous bought at was CHF 104.924. The current market price is -15.3% lower than average price they were purchased at. The value of the holding in SFZN.SW has increased by CHF 6,009 (USD $7,536) compared to the previous valuation of however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 46.74 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 46.74. The average price that SHL.DE shares were previous bought at was EUR 47.75. The current market price is -2.1% lower than average price they were purchased at. The value of the holding in SHL.DE has fallen by EUR 32,539 (USD $37,963) compared to the previous valuation of Siemens Healthineers AG |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 13.8741 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 13.8741. The average price that SN.L shares were previous bought at was GBP 12.8575. The current market price is 7.9% higher than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 225,238 (USD $303,298) compared to the previous valuation of Smith & Nephew PLC |
| SOBI.ST - | HOLD | 0 @ SEK 31.328 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 31.328. The average price that SOBI.ST shares were previous bought at was SEK 26.7916. The current market price is 16.9% higher than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 14,937 (USD $1,630) compared to the previous valuation of however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 237.792 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 237.792. The average price that SOON.SW shares were previous bought at was CHF 268.015. The current market price is -11.3% lower than average price they were purchased at. The value of the holding in SOON.SW has increased by CHF 196,248 (USD $246,122) compared to the previous valuation of however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 259.7 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 259.7. The average price that SRT3.DE shares were previous bought at was EUR 217.994. The current market price is 19.1% higher than average price they were purchased at. The value of the holding in SRT3.DE has fallen by EUR 5,435 (USD $6,341) compared to the previous valuation of Sartorius AG |
| STMN.SW - | HOLD | 0 @ CHF 107.414 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 107.414. The average price that STMN.SW shares were previous bought at was CHF 112.761. The current market price is -4.7% lower than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 53,032 (USD $66,509) compared to the previous valuation of |
| TECN.SW - | HOLD | 0 @ CHF 169.438 | CHF 0 | The current share valuation price of TECN.SW based on adjusted close was CHF 169.438. The average price that TECN.SW shares were previous bought at was CHF 175.966. The current market price is -3.7% lower than average price they were purchased at. The value of the holding in TECN.SW has fallen by CHF 16,369 (USD $20,529) compared to the previous valuation of |
| TUB.BR - Financiere de Tubize SA | HOLD | 0 @ EUR 226 | EUR 0 | The current share valuation price of TUB.BR based on adjusted close was EUR 226. The average price that TUB.BR shares were previous bought at was EUR 134.464. The current market price is 68.1% higher than average price they were purchased at. The value of the holding in TUB.BR has increased by EUR 27,642 (USD $32,250) compared to the previous valuation of Financiere de Tubize SA however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 254.2 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 254.2. The average price that UCB.BR shares were previous bought at was EUR 167.894. The current market price is 51.4% higher than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 123,627 (USD $144,235) compared to the previous valuation of UCB SA however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| ZEAL.CO - | HOLD | 0 @ DKK 54.8679 | DKK 0 | The current share valuation price of ZEAL.CO based on adjusted close was DKK 54.8679. The average price that ZEAL.CO shares were previous bought at was DKK 59.1439. The current market price is -7.2% lower than average price they were purchased at. The value of the holding in ZEAL.CO has fallen by DKK 1,939 (USD $303) compared to the previous valuation of |
| DEMANT.CO - | HOLD | 0 @ DKK 31.1811 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 31.1811. The average price that DEMANT.CO shares were previous bought at was DKK 35.1227. The current market price is -11.2% lower than average price they were purchased at. The value of the holding in DEMANT.CO has increased by DKK 38,389 (USD $5,995) compared to the previous valuation of however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| ALC.SW - | HOLD | 0 @ CHF 69.1701 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 69.1701. The average price that ALC.SW shares were previous bought at was CHF 77.0204. The current market price is -10.2% lower than average price they were purchased at. The value of the holding in ALC.SW has fallen by CHF 22,264 (USD $27,922) compared to the previous valuation of |
| ALK-B.CO - | HOLD | 0 @ DKK 30.5119 | DKK 0 | The current share valuation price of ALK-B.CO based on adjusted close was DKK 30.5119. The average price that ALK-B.CO shares were previous bought at was DKK 24.063. The current market price is 26.8% higher than average price they were purchased at. The value of the holding in ALK-B.CO has increased by DKK 12,649 (USD $1,975) compared to the previous valuation of however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| AMBU-B.CO - | HOLD | 0 @ DKK 12.178 | DKK 0 | The current share valuation price of AMBU-B.CO based on adjusted close was DKK 12.178. The average price that AMBU-B.CO shares were previous bought at was DKK 13.7187. The current market price is -11.2% lower than average price they were purchased at. The value of the holding in AMBU-B.CO has increased by DKK 16,787 (USD $2,621) compared to the previous valuation of however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| AMP.MI - Amplifon SpA | HOLD | 0 @ EUR 13.665 | EUR 0 | The current share valuation price of AMP.MI based on adjusted close was EUR 13.665. The average price that AMP.MI shares were previous bought at was EUR 19.8189. The current market price is -31.1% lower than average price they were purchased at. The value of the holding in AMP.MI has increased by EUR 2,835 (USD $3,308) compared to the previous valuation of Amplifon SpA however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 697 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 697. The average price that ARGX.BR shares were previous bought at was EUR 525.504. The current market price is 32.6% higher than average price they were purchased at. The value of the holding in ARGX.BR has increased by EUR 672,512 (USD $784,618) compared to the previous valuation of Argenx SE however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 161.553 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 161.553. The average price that AZN.L shares were previous bought at was GBP 127.143. The current market price is 27.1% higher than average price they were purchased at. The value of the holding in AZN.L has fallen by GBP 890,183 (USD $1,198,690) compared to the previous valuation of AstraZeneca PLC |
| BAVA.CO - | HOLD | 0 @ DKK 26.7247 | DKK 0 | The current share valuation price of BAVA.CO based on adjusted close was DKK 26.7247. The average price that BAVA.CO shares were previous bought at was DKK 23.0839. The current market price is 15.8% higher than average price they were purchased at. The value of the holding in BAVA.CO has increased by DKK 5,233 (USD $817) compared to the previous valuation of however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 38.945 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 38.945. The average price that BAYN.DE shares were previous bought at was EUR 26.2448. The current market price is 48.4% higher than average price they were purchased at. The value of the holding in BAYN.DE has fallen by EUR 325,894 (USD $380,220) compared to the previous valuation of Bayer AG |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 108 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 108. The average price that BIM.PA shares were previous bought at was EUR 118.427. The current market price is -8.8% lower than average price they were purchased at. The value of the holding in BIM.PA has fallen by EUR 29,371 (USD $34,267) compared to the previous valuation of BioMerieux |
| CAMX.ST - | HOLD | 0 @ SEK 63.8042 | SEK 0 | The current share valuation price of CAMX.ST based on adjusted close was SEK 63.8042. The average price that CAMX.ST shares were previous bought at was SEK 56.2613. The current market price is 13.4% higher than average price they were purchased at. The value of the holding in CAMX.ST has increased by SEK 7,627 (USD $832) compared to the previous valuation of however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| COLO-B.CO - | HOLD | 0 @ DKK 77.1363 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 77.1363. The average price that COLO-B.CO shares were previous bought at was DKK 85.2136. The current market price is -9.5% lower than average price they were purchased at. The value of the holding in COLO-B.CO has increased by DKK 23,046 (USD $3,599) compared to the previous valuation of however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| CTEC.L - ConvaTec Group PLC | HOLD | 0 @ GBP 2.72177 | GBP 0 | The current share valuation price of CTEC.L based on adjusted close was GBP 2.72177. The average price that CTEC.L shares were previous bought at was GBP 3.01533. The current market price is -9.7% lower than average price they were purchased at. The value of the holding in CTEC.L has fallen by GBP 82,487 (USD $111,074) compared to the previous valuation of ConvaTec Group PLC |
| ABVX.PA - Abivax SA | HOLD | 0 @ EUR 104 | EUR 0 | The current share valuation price of ABVX.PA based on adjusted close was EUR 104. The average price that ABVX.PA shares were previous bought at was EUR 100.227. The current market price is 3.8% higher than average price they were purchased at. EUR 0 (USD $0) compared to the previous valuation of Abivax SA however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 214.7 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 214.7. The average price that DIM.PA shares were previous bought at was EUR 199.575. The current market price is 7.6% higher than average price they were purchased at. The value of the holding in DIM.PA has fallen by EUR 3,593 (USD $4,192) compared to the previous valuation of Sartorius Stedim Biotech |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 278 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 278. The average price that EL.PA shares were previous bought at was EUR 250.248. The current market price is 11.1% higher than average price they were purchased at. The value of the holding in EL.PA has increased by EUR 271,190 (USD $316,397) compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 73.12 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 73.12. The average price that ERF.PA shares were previous bought at was EUR 58.4412. The current market price is 25.1% higher than average price they were purchased at. The value of the holding in ERF.PA has increased by EUR 72,951 (USD $85,112) compared to the previous valuation of Eurofins Scientific SE however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 39.34 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 39.34. The average price that FME.DE shares were previous bought at was EUR 47.4075. The current market price is -17.0% lower than average price they were purchased at. The value of the holding in FME.DE has fallen by EUR 118,392 (USD $138,128) compared to the previous valuation of Fresenius Medical Care AG |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 51.24 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 51.24. The average price that FRE.DE shares were previous bought at was EUR 42.8728. The current market price is 19.5% higher than average price they were purchased at. The value of the holding in FRE.DE has increased by EUR 92,670 (USD $108,118) compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| GALD.SW - | HOLD | 0 @ CHF 170.511 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 170.511. The average price that GALD.SW shares were previous bought at was CHF 128.821. The current market price is 32.4% higher than average price they were purchased at. The value of the holding in GALD.SW has fallen by CHF 386,513 (USD $484,741) compared to the previous valuation of |
| GETI-B.ST - | HOLD | 0 @ SEK 20.6862 | SEK 0 | The current share valuation price of GETI-B.ST based on adjusted close was SEK 20.6862. The average price that GETI-B.ST shares were previous bought at was SEK 17.466. The current market price is 18.4% higher than average price they were purchased at. The value of the holding in GETI-B.ST has increased by SEK 16,300 (USD $1,778) compared to the previous valuation of however if the holding was sold on 2026-01-13 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 287.187 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 287.187. The average price that GMAB.CO shares were previous bought at was DKK 192.304. The current market price is 49.3% higher than average price they were purchased at. The value of the holding in GMAB.CO has fallen by DKK 60,060 (USD $9,379) compared to the previous valuation of |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 10.91 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 10.91. The average price that GRF.MC shares were previous bought at was EUR 10.445. The current market price is 4.5% higher than average price they were purchased at. The value of the holding in GRF.MC has fallen by EUR 20,388 (USD $23,787) compared to the previous valuation of Grifols SA |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 21.4282 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 21.4282. The average price that GSK.L shares were previous bought at was GBP 17.2647. The current market price is 24.1% higher than average price they were purchased at. The value of the holding in GSK.L has fallen by GBP 394,759 (USD $531,569) compared to the previous valuation of GlaxoSmithKline PLC |
| HIK.L - | HOLD | 0 @ GBP 17.7376 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 17.7376. The average price that HIK.L shares were previous bought at was GBP 23.5355. The current market price is -24.6% lower than average price they were purchased at. The value of the holding in HIK.L has fallen by GBP 22,161 (USD $29,841) compared to the previous valuation of |